跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBRANCE 125 mg capsule - SFDA Drug Approval Details
Approvals
/
SFDA
/
IBRANCE 125 mg capsule
Authorized
NCE
IBRANCE 125 mg capsule
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
459f9ca0d71c8c4a
Company
Unknown
Type
NCE
Approval Details
Approval Id
459f9ca0d71c8c4a
Drug Approval Sfda Name
IBRANCE 125 mg capsule
Trade Name
IBRANCE 125 mg capsule
Generic Name
PALBOCICLIB
Register Number
1111211307
Register Year
2016
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Bottle
Package Size
21
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000000951-125-200000016452
Price
12172.95
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
459f9ca0d71c8c4a
Type
NCE
Back to SFDA Approvals